Regulatory Roundup: FDA approves new-look self-expanding stent, clears 2 advanced AI models

Echo:Prio represents the latest addition to Dyad Medical's cloud-based Libby platform. Image courtesy of Dyad Medical.
Echo:Prio represents the latest addition to Dyad Medical's cloud-based Libby platform. Image courtesy of Dyad Medical.

The FDA has had a busy month, overseeing the recall of nearly 88,000 implantable cardiac devices, juggling the continued rise of monkeypox cases in the United States and maintaining an active Breakthrough Devices program. This rundown covers some of the agency's biggest moves during that time. 

Employer healthcare plan costs will rise again next year

insurance payer payment insurer

"In complete contrast over the last decades, we are measuring that healthcare budgets for U.S. employers will come in nearly three times lower than the Consumer Price Index this calendar year. Despite this historic occurrence, employer health costs are expected to increase 6.5[%] in 2023 due to economic inflation pressures," says Debbie Ashford, North America chief actuary for health solutions at Aon.